Search

Ikänik Farms Completes Cooperation Agreement with SGS Colombia SAS, to develop a Certification

CORONA, California, April 12, 2021 / CNW / - Ikänik Farms, Inc. (CSE: IKNK.U) ("Ikänik Farms" or the "Company") is pleased to announce that Pideka SAS. ("Pideka"), a 100% subsidiary of Ikänik Farms, has successfully concluded its cooperation agreement with SGS Colombia SAS ("SGS") to design, initiate, develop and implement a normative standard for the international certification of medicinal cannabis. This certification works to establish a new reference standard for the quality and safety of cannabis pharmaceutical products known as the "GPTCP", or "Good Transformation and Commercialization Practices of Cannabis Pharma Production".



"Completing this certificate of collaboration with SGS Colombia is a milestone and a reflection of the company's dedication to best-in-class quality for the cannabis industry." said Brian Baca, CEO of Ikänik Farms.


About GPTCP certification



The GPTCP certificate guarantees that the company maintains international standards and differentiates itself by adhering to a world reference standard of quality for the production of cannabis.


With the collaborative development of the SGS certified seal of self-regulation and sustainability, industry best practices are promoted and a competitive approach to quality is fostered, through best-in-class and industry-standardized processes, to provide consumers end confidence in the product.


The GPTCP covers facets of the requirements under various standards such as BPA, BPM, INVIMA, ICA, ISO 9001, SG-SST, EUGMP both nationally (Colombian) and internationally.



The quality certification and delivery of high caliber products is one of the Company's key objectives, supported through operational certifications obtained for its operations, including (GACP, GMP FARMA, ISO-9001, and EUGMP).



About SGS Colombia SAS


SGS Colombia SAS is a subsidiary of SGS SA, one of the world's leading inspection, verification, testing and certification companies. SGS is recognized as a global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of more than 2,600 offices and laboratories around the world.


About Ikänik Farms


Ikänik Farms is a California-based multinational operator (MNO) that is building a dynamic portfolio of brands, inspired by passion, health and wellness, action sports, and supported by its vertically integrated retailer, distribution and cultivation in CA and its medical and laboratory grade culture in Colombia. The company's leadership brings decades of experience in R&D, cultivation, retail, branding, and corporate finance. The Ikänik Farms operation in Colombia, through its pharmaceutical division Pideka, holds the GMP-PHARMA and (GACP) Good Agricultural and Collection Practices certifications for its operational facility at Casa Flores.



Forward-Looking Statements



This press release includes "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws and US securities laws (collectively, "forward-looking information). All information, other than statements of historical fact, including in this press release that addresses activities, events or developments that the Company expects or anticipates will or may occur in the future is forward-looking information. When used in this press release, words such as "will", "may", " planned "," estimated "," expected "," intends "," must "," potential "," believes "," must ", and similar expressions are forward-looking information.



Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking information, there may be other factors that cause results, results or achievements other than those anticipated, estimated. or anticipated, including but not limited to changes in laws, a change in management, inability to obtain additional funding, increased competition, hampering market growth, and state adoption due to inconsistent public opinion and industry perception of the medical use and adult use of marijuana, and regulatory or political change.



There can be no guarantee that such information will be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in the forward-looking information may differ materially from the actual results or events.


Consequently, readers should not unduly trust forward-looking information. The forward-looking information in this press release is made as of the date of this release. The Company declines any intention or obligation to update or revise such information, except as required by applicable law, and the Company assumes no responsibility for disclosure related to any other company mentioned in this document.



On behalf of the Board of Directors of Ikänik Farms Inc.


SOURCE Ikänik Farms Inc.


For more information: Investor Relations: ir@ikanikfarms.com, +1 951-210-7250


related links

https://ikanikfarms.com/

15 views0 comments